scholarly article | Q13442814 |
P2093 | author name string | Lee TH | |
Watson R | |||
Imamura S | |||
Busch MP | |||
Reed W | |||
Ariga H | |||
Ohto H | |||
P2860 | cites work | A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif | Q24301723 |
Isolation of fetal DNA from nucleated erythrocytes in maternal blood | Q24558688 | ||
Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum | Q24567463 | ||
Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting | Q24598225 | ||
Simultaneous amplification and detection of specific DNA sequences | Q28185655 | ||
Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis | Q28268533 | ||
Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis | Q34065286 | ||
Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies | Q35249607 | ||
Development of non-invasive fetal DNA diagnosis from maternal blood | Q36702786 | ||
Detection of soluble HLA-G levels in maternal serum can be predictive for a successful pregnancy | Q40809432 | ||
Detection of soluble HLA-G molecules in plasma and amniotic fluid | Q40966607 | ||
A class I antigen, HLA-G, expressed in human trophoblasts | Q41737375 | ||
Detection of fetal HPCs in maternal circulation after delivery | Q43584977 | ||
Quantitation of white cell subpopulations by polymerase chain reaction using frozen whole-blood samples. Viral Activation Transfusion Study | Q46652422 | ||
The time of appearance and disappearance of fetal DNA from the maternal circulation | Q47336776 | ||
Charge flow separation: quantification of nucleated red blood cells in maternal blood during pregnancy | Q47989474 | ||
Disturbed feto-maternal cell traffic in preeclampsia. | Q50891524 | ||
Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. | Q53782517 | ||
Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
Cell-free fetal deoxyribonucleic acid in maternal circulation as a marker of fetal-maternal hemorrhage in patients undergoing external cephalic version near term | Q58029876 | ||
P433 | issue | 12 | |
P304 | page(s) | 1524-1530 | |
P577 | publication date | 2001-12-01 | |
P1433 | published in | Transfusion | Q15758500 |
P1476 | title | Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis | |
P478 | volume | 41 |
Q37475111 | A Previous Miscarriage and a Previous Successful Pregnancy Have a Different Impact on HLA Antibody Formation during a Subsequent Successful Pregnancy |
Q35670166 | Absence of transfusion-associated microchimerism in pediatric and adult recipients of leukoreduced and gamma-irradiated blood components |
Q36041489 | Alterations in maternal-fetal cellular trafficking after fetal surgery |
Q37705082 | Analysis of maternal microchimerism in rhesus monkeys (Macaca mulatta) using real-time quantitative PCR amplification of MHC polymorphisms |
Q57937765 | Application of nucleic acid amplification tests to study transfusion-associated microchimerism – a new complication of blood transfusions in trauma patients |
Q38089828 | Beneficial or harmful effect of antipaternal human leukocyte antibodies on pregnancy outcome? A systematic review and meta-analysis |
Q35589383 | Biological implications of bi-directional fetomaternal cell traffic: a summary of a National Institute of Child Health and Human Development-sponsored conference. |
Q28236386 | Birth order and sibling sex ratio of children and adolescents referred to a gender identity service |
Q28250353 | Birth weight and two possible types of maternal effects on male sexual orientation: a clinical study of children and adolescents referred to a Gender Identity Service |
Q51634778 | CD34+ cells in maternal placental blood are mainly fetal in origin and express endothelial markers. |
Q37079376 | Cell migration from baby to mother |
Q90675913 | Cell-Free DNA Release by Mouse Fetal Membranes |
Q89660275 | Cell-Free Fetal DNA Increases Prior to Labor at Term and in a Subset of Preterm Births |
Q38541725 | Cell-Free Fetal DNA, Telomeres, and the Spontaneous Onset of Parturition |
Q33806881 | Cell-free DNA release by mouse placental explants |
Q35966472 | Cell-free fetal DNA in maternal blood: kinetics, source and structure |
Q28268297 | Comprehensive analysis of genes expressed by rare microchimeric fetal cells in the maternal mouse lung |
Q36012465 | Demonstration of microchimerism in pregnant sows and effects of congenital PRRSV infection |
Q44432964 | Detecting fetal DNA from dried maternal blood spots: another step towards broad scale non-invasive prenatal genetic screening and feasible testing |
Q37957143 | Developing immunologic tolerance for transplantation at the fetal stage. |
Q57913890 | Fetal Cell Microchimerism, a Low-Grade Naturally Occurring Celltherapy |
Q41912007 | Fetal and Placental DNA Stimulation of TLR9: A Mechanism Possibly Contributing to the Pro-inflammatory Events During Parturition |
Q36861150 | Fetal blood group genotyping. |
Q37630585 | Fetal cell microchimerism in cancer: a meaningful event? |
Q41457906 | Fetal cell microchimerism in the maternal mouse spinal cord |
Q35835705 | Fetal cell-free nucleic acids in the maternal circulation: new clinical applications |
Q37071912 | Fetal microchimeric cells participate in tumour angiogenesis in melanomas occurring during pregnancy |
Q36712795 | Feto-maternal cell trafficking: a transfer of pregnancy associated progenitor cells. |
Q36797045 | Fragment size analysis of free fetal DNA in maternal plasma using Y-STR loci and SRY gene amplification. |
Q34567523 | Functional HY-specific CD8+ T cells are found in a high proportion of women following pregnancy with a male fetus |
Q46702086 | Genomewide association study of HLA alloimmunization in previously pregnant blood donors |
Q35870528 | Genomic and proteomic investigation of preeclampsia |
Q35124977 | HY immune tolerance is common in women without male offspring |
Q53143680 | High concordance of subtypes of childhood acute lymphoblastic leukemia within families: lessons from sibships with multiple cases of leukemia. |
Q51275296 | High male chimerism in the female breast shows quantitative links with cancer. |
Q40207944 | Hypoxia-induced membrane-bound apoptotic DNA particles: potential mechanism of fetal DNA in maternal plasma |
Q38686693 | Immunological implications of pregnancy-induced microchimerism. |
Q91695924 | Immunomodulatory effects of interferon-γ on human fetal cardiac mesenchymal stromal cells |
Q36793031 | Impact of fetal-maternal microchimerism on women's health--a review |
Q57071392 | Incognito: Are Microchimeric Fetal Stem Cells that Cross Placental Barrier Real Emissaries of Peace? |
Q36535733 | Increased maternal microchimerism after open fetal surgery |
Q37529449 | Investigating and correcting plasma DNA sequencing coverage bias to enhance aneuploidy discovery |
Q51757108 | Local and circulating microchimerism is associated with hypersensitivity pneumonitis. |
Q99711502 | MAIT Cells at the Fetal-Maternal Interface During Pregnancy |
Q34890939 | Male microchimerism in peripheral blood leukocytes from women with multiple sclerosis |
Q35629442 | Maternal neoangiogenesis during pregnancy partly derives from fetal endothelial progenitor cells. |
Q33838736 | Maternal-fetal cellular trafficking: clinical implications and consequences |
Q52632153 | Maternal-fetal cross talk through cell-free fetal DNA, telomere shortening, microchimerism, and inflammation. |
Q48217077 | Mechanistic Sharing Between NK Cells in ABMR and Effector T Cells in TCMR. |
Q34794043 | Microchimerism: covert genetics? |
Q34503692 | Migration of microchimeric fetal cells into maternal circulation before placenta formation |
Q46008328 | Minimum conditions of major histocompatibility complex compatibility and recipient immune compromise required to establish donor white blood cell persistence in a murine transfusion model. |
Q28081268 | Molecular Regulation of Parturition: The Role of the Decidual Clock |
Q89533651 | Multiomic immune clockworks of pregnancy |
Q33921152 | Naturally acquired microchimerism |
Q77961995 | Non-invasive determination of the paternal HLA haplotype of a fetus using kinetic PCR to detect fetal microchimerism in maternal plasma |
Q56001887 | Non-invasive fetal RHD genotyping in the first trimester of pregnancy |
Q38182095 | Noninvasive prenatal testing: the future is now. |
Q38690719 | Novel insights into the link between fetal cell microchimerism and maternal cancers |
Q43861652 | Nucleic acid-based non-invasive prenatal diagnosis of genetic skin diseases: are we ready? |
Q37822751 | Placental microparticles, DNA, and RNA in preeclampsia |
Q78738090 | Prediction of fetal Rh D and Rh CcEe phenotype from maternal plasma with real-time polymerase chain reaction |
Q57913876 | Pregnancy-Acquired Fetal Progenitors as Natural Cell Therapy |
Q35168846 | Pregnancy-associated progenitor cells: an under-recognized potential source of stem cells in maternal lung |
Q37322448 | Prenatal diagnosis: update on invasive versus noninvasive fetal diagnostic testing from maternal blood |
Q38598829 | Programmed Fetal Membrane Senescence and Exosome-Mediated Signaling: A Mechanism Associated With Timing of Human Parturition |
Q36152318 | Prospective assessment of fetal-maternal cell transfer in miscarriage and pregnancy termination |
Q33696661 | Quantification of green fluorescent protein by in vivo imaging, PCR, and flow cytometry: comparison of transgenic strains and relevance for fetal cell microchimerism |
Q37000825 | Recent advances in non-invasive prenatal DNA diagnosis through analysis of maternal blood. |
Q28305222 | Sexual orientation, fraternal birth order, and the maternal immune hypothesis: a review |
Q53610426 | Sharpening the tools: a summary of a National Institutes of Health workshop on new technologies for detection of fetal cells in maternal blood for early prenatal diagnosis. |
Q45238487 | Significance of the volume of fetomaternal hemorrhage after performing prenatal invasive tests |
Q28681584 | Stem cell potency and the ability to contribute to chimeric organisms |
Q35084713 | Stem cells and female reproduction |
Q92538569 | The Cellular Transcriptome in the Maternal Circulation During Normal Pregnancy: A Longitudinal Study |
Q89936452 | The Fetal-Maternal Immune Interface in Uterus Transplantation |
Q34129544 | The Role of Transplacental Microtransfusions of Maternal Lymphocytes in In Utero HIV Transmission |
Q35879299 | The biology and diagnostic applications of fetal DNA and RNA in maternal plasma |
Q41202120 | The effect of chorionic villus sampling on the fraction of cell-free fetal DNA in maternal plasma |
Q93032384 | The impact of previous live births on peripheral and uterine natural killer cells in patients with recurrent miscarriage |
Q36535728 | The natural history of fetal cells in postpartum murine maternal lung and bone marrow: a two-stage phenomenon |
Q33951209 | The role of fetal microchimerism in autoimmune disease. |
Q36433157 | The role of transplacental microtransfusions of maternal lymphocytes in HIV transmission to newborns |
Q100385395 | Three non-classical mechanisms for anemic disease of the fetus and newborn, based on maternal anti-Kell, anti-Ge3, anti-M, and anti-Jra cases |
Q40607413 | Tissue microchimerism is increased during pregnancy: a human autopsy study |
Q26995586 | Tracking fetal development through molecular analysis of maternal biofluids |
Q36456960 | Transfusion-associated microchimerism: the hybrid within |
Q33960301 | Vascular endothelial expression of indoleamine 2,3-dioxygenase 1 forms a positive gradient towards the feto-maternal interface |
Q36846208 | We are all born as microchimera |
Q38911516 | Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance |
Q87340257 | [Non-invasive fetal RHD genotyping: Validation of the method with 200 patients] |
Q54645596 | [Prenatal determination of fetal RHD in maternal plasma: two-years experience of routine clinical use] |
Search more.